Phoebe Physician Group Inc
Analysis
Phoebe Physician Group Inc is a registered charity in United States, based in Albany, GA. It received its IRS tax-exemption ruling in September 2012, 14 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (gross receipts test) under section 501(c)(3), and contributions to it are listed as tax-deductible.
In the financial year ending July 2023, Phoebe Physician Group Inc reported income of $223.6m and spending of $223.6m, spending 100% of its income. Across the 5 years on record, from July 2019 to July 2023, income grew from $185.6m to $223.6m (+20%), an average of +4.8% a year. Over the whole period it spent 100% of the income it received.
Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Phoebe Physician Group Inc sits at the 97th percentile: it is larger than about 97% of them. Against every charity in United States with reported income it ranks in the 100th percentile, and in the 100th percentile within GA. Charities of a similar size with the same main cause include University Hospital & Clinics Inc ($222.7m), Breakthrough T1d ($223.8m) and United Cerebral Palsy of New York City Inc ($221.7m).
On its Form 990 for the period ending July 2023, revenue came from program service revenue 44% of the total. Compensation of current officers, directors and key employees was $9.4m (4.2% of expenses). Other salaries and wages came to $139.0m. At year end it held assets of $41.8m against liabilities of $44.2m, net assets of -$2.4m. It reported 1,167 employees.
Income and spending
Where the income comes from
- Program services 44%
- Other 56%
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| University Hospital & Clinics Inc | Lafayette | $222.7m |
| Breakthrough T1d | New York | $223.8m |
| United Cerebral Palsy of New York City Inc | New York | $221.7m |
| St Lukes Hospital-Monroe Campus | Allentown | $225.2m |